Elixxer Company Insiders
ELXR Stock | CAD 1.15 0.00 0.00% |
Elixxer employs about 17 people. The company is managed by 17 executives with a total tenure of roughly 65 years, averaging almost 3.0 years of service per executive, having 1.0 employees per reported executive. Recap of Elixxer's management performance can provide insight into the venture performance.
Elixxer |
Elixxer Management Team Effectiveness
The company has return on total asset (ROA) of (0.3042) % which means that it has lost $0.3042 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (10.1376) %, meaning that it generated substantial loss on money invested by shareholders. Elixxer's management efficiency ratios could be used to measure how well Elixxer manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Elixxer's Total Current Assets are fairly stable compared to the past year. Net Tangible Assets is likely to climb to about 8.8 M in 2024, whereas Total Assets are likely to drop slightly above 5.9 M in 2024.Common Stock Shares Outstanding is likely to drop to about 9.7 M in 2024. Net Loss is likely to drop to about (17.1 M) in 2024
Elixxer Workforce Comparison
Elixxer is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 9,042. Elixxer adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Elixxer Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Elixxer Price Series Summation is a cross summation of Elixxer price series and its benchmark/peer.
Elixxer Notable Stakeholders
An Elixxer stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Elixxer often face trade-offs trying to please all of them. Elixxer's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Elixxer's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mazen Haddad | Co-Chairman of the Board, Chief Executive Officer | Profile | |
CPA CMA | Corporate CFO | Profile | |
Kym No | Interim Chief Financial Officer | Profile | |
Remy Meglio | Chief Operating Officer | Profile | |
Mohammed Ghafari | Independent Director | Profile | |
Daniel Lubienietzky | VP Development | Profile | |
David Lenigas | Co-Chairman of the Board | Profile | |
Anthony Samaha | Director | Profile | |
Jeanne Wyk | Vice Communications | Profile | |
Michael Kozub | Corporate Secretary | Profile | |
Jeff Cheah | Director | Profile | |
John McMullen | President | Profile | |
Richard Widmann | EVP Commercial | Profile | |
Tarik Alhaidary | Director | Profile | |
Ferras Zalt | Executive Chairman of the Board | Profile | |
Rafi Hazan | Director | Profile | |
LLB LLB | Legal Council | Profile |
About Elixxer Management Performance
The success or failure of an entity such as Elixxer often depends on how effective the management is. Elixxer management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Elixxer management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Elixxer management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. ELIXXER is traded on Commodity Exchange in Exotistan.
Please note, the imprecision that can be found in Elixxer's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Elixxer. Check Elixxer's Beneish M Score to see the likelihood of Elixxer's management manipulating its earnings.
Elixxer Workforce Analysis
Traditionally, organizations such as Elixxer use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Elixxer within its industry.Elixxer Manpower Efficiency
Return on Elixxer Manpower
Revenue Per Employee | 4.8K | |
Revenue Per Executive | 4.8K | |
Net Loss Per Employee | 362.8K | |
Net Loss Per Executive | 362.8K |
Additional Tools for Elixxer Stock Analysis
When running Elixxer's price analysis, check to measure Elixxer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixxer is operating at the current time. Most of Elixxer's value examination focuses on studying past and present price action to predict the probability of Elixxer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixxer's price. Additionally, you may evaluate how the addition of Elixxer to your portfolios can decrease your overall portfolio volatility.